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Abstract
Introduction: Approximately 55% of women in Europe die from cardiovascular events, mostly as a result of 
coronary diseases and cerebral stroke. There is a 10-year shift in the cardiovascular risk between women and 
men. The risk in a 55-year-old female patient is similar to that of a 45-year-old man, thus the risk among women 
increases rapidly around the age of 50, when menopause prevails to occur. The purpose of the study was to 
assess and compare the SCORE-predicted risk of a fatal cardiovascular incident in pre- and postmenopausal 
women.
Material and methods: The cross-sectional study was conducted as part of community nursing practice.  
It covered 219 women – inhabitants of Krakow, aged from 30 to 65, without clinically validated cardiovascular 
diseases of arteriosclerotic and/or diabetic origin, who volunteered to take part in the study. The group was 
divided into three subgroups: K1 – menstruating women (n = 113), K2a – women after natural menopause  
(n = 88), and K2b – women after surgical menopause (n = 18). The study made use of a lifestyle questionnaire, 
which concerned the social and economic status, and lifestyle habits including tobacco smoking. Arterial blood 
pressure was measured, and total cholesterol concentration in blood (mmol/l) was recorded.
Results: A high (≥ 5%) level of the SCORE risk was discovered in 14.3% of postmenopausal women, as 
compared to 0.9% in the group of menstruating women. An average risk of a fatal cardiovascular incident dur-
ing the following 10 years was significantly higher among women from groups K2a (2.61%) and K2b (2.32%) 
as compared to K1 – menstruating women (0.38%). No difference was, however, discovered between groups of 
naturally (K2a) and surgically menopausal women (K2b).
Conclusions: A significantly higher risk of SCORE-predicted death caused by a cardiovascular incident, as 
compared to the group of women in the premenopausal period, is characteristic of women in the postmeno-
pausal period.
Key words: cardiovascular risk, SCORE system, woman, menopause. 
Introduction 
Cardiovascular disease (CVD) is considered to be the 
most common cause of death among women in Europe. 
About 53% of female deaths are due to CVD, particularly 
coronary heart disease (CHD) and stroke [1]. Coronary 
heart disease mortality in women increases after the 
sixth decade of life. Most women become menopau-
sal before this age [2]. More women than men die of 
CHD. More women have died from CVD than of cancer 
(including breast cancer), Alzheimer disease, chronic 
lower respiratory disease, and accidents combined [3]. 
The consequences of coronary artery disease (CAD) are 
worse in women than in men. Among individuals with 
premature myocardial infarction (MI) (under 50 years of 
age), women experience a  twice-fold higher mortality 
rate after acute MI compared to men [4].
The cardiovascular risk in women is shifted by 10 
years as compared to men. Some publications show 
that the risk in 55-year-old women is similar to that in 
45-year-old men [5, 6]. A low level of the absolute risk in 
a young, menstruating woman may obscure a high rela-
tive risk that would result in the absolute risk growing 
with age [7, 8]. Lowering CVD-related mortality in the 
recent years is more beneficial in the group of men than 
in women, in whom increased frequency of CVD contin-
ues to be reported, especially in older age cohorts [5, 6].
The guidelines (2003) of the European Society of 
Cardiology (ESC) introduced SCORE (Systemic Coronary 
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Risk Evaluation), a risk assessment system based on re-
sults achieved in 12 European cohort studies involving 
93,298 women. The strategy for coping with high-risk 
patients, in whom the risk exceeds 5%, should aim at 
reducing the risk both with non-pharmacological and 
pharmacological methods [7].
Recommendations of the ESC in 2006 concerning 
CVD in women cover mainly the collection of epidemio-
logical data on CVD and risk factors in women in differ-
ent age ranges [8].
Hence the importance of a lifestyle change in order 
to avoid the high cardiovascular risk in the older age 
can be inferred. It is also required to direct both public 
health policy on the European and country level and in-
dividual contact between the healthcare professionals 
and patients, and also to include women in educational 
and motivational activities.
The goal of the studies was to assess and compare 
the risk of death due to SCORE-predicted cardiovascu-
lar incidents in the groups of women before and after 
menopause.
Material and methods
The research program covered 250 women inhabit-
ing Krakow, who were included in the care of two family 
and community nursing practices operating in the Nowa 
Huta district. The respondent population consisted of 
women involved in the primary CVD prevention pro-
gramme “Zdrowie dla Twojego Serca” [Health for your 
heart]. The following inclusion criteria were assumed: 
female gender, age in the range 30-65 years, no CVD 
or diabetes diagnosed or treated. The exclusion criteria 
were as follows: any previous CVD or diabetes diagno-
sis, taking cardiological medicines, age over 65 years or 
below 30 years, cognitive disorders precluding the pa-
tient from giving medical history. Only 219 women were 
qualified for the final analysis because of giving up or 
unsatisfactory co-operation of some patients.
The group was divided into premenopausal – K1 
(n = 113) and postmenopausal – K2 (n = 106) subgroups 
of women, with the latter group being composed of 88 
naturally (K2a) and 18 surgically menopausal women 
(K2b).
The study made use of a proprietary lifestyle ques-
tionnaire, which contained questions concerning the 
social and economic status, and lifestyle including to-
bacco smoking. 
The arterial blood pressure measurements were 
carried out by means of S. Riva-Rocci method modi-
fied by Korotkov on the brachial artery of the left and 
right upper extremities with the use of dial (aneroid) 
sphygmomanometer. The measurements were carried 
out in patients at steady state, after at least 5 minutes 
of rest, in a sitting position. The measurements were re-
peated after an interval of 3 minutes [9]. In the analysis, 
the mean of two measurements was used. The venous 
blood samples were taken on after fasting (at least 12 h 
after the last meal) in the closed Vacutainer system 
according to the procedures and to the nurse practice 
standards [10]. The total cholesterol (TCh) (mmol/l) was 
determined by the dry chemistry methodology with the 
use of VITROS 250 device in the Department of Clinical 
Immunochemistry of the Second Department of Medi-
cine, Jagiellonian University Medical College.
The diagnostic survey has been performed with the 
use of original author’s inventory on the menopause 
status and on using the hormone contraception or hor-
mone replacement therapy.
Natural menopause was defined according to the 
World Health Organization (WHO) definition stating 
that menopause is the permanent cessation of men-
struation resulting from the loss of ovarian follicular 
activity. Natural menopause is recognised to occur af-
ter 12 consecutive months of amenorrhea, for no other 
pathological or physiological cause [11].
The SCORE system, developed by the ESC on the 
grounds of cohort studies, was used to assess the risk 
of death in the coming 10 years. The system uses five 
risk factors, namely age, sex, systolic blood pressure, to-
tal cholesterol, and smoking to evaluate the total risk of 
death due to cardiovascular incidents in the following 
10 years. Following the 2007 and 2012 guideline up-
dates, the value of ≥ 5%, deemed to justify introduction 
of a high-risk strategy, was assumed as the threshold 
of an elevated risk of death due to a cardiovascular in-
cident. The SCORE chart for women in countries consid-
ered high-risk ones according to the European guide-
lines on cardiovascular prevention in clinical practice 
for 2012 was used [12, 13]. 
The data were analysed with the use of SPSS 14.0 
and STATISTICA 6.1 PL packages. Variance analysis for 
differences between the groups was performed using 
post-hoc tests (F REGWi, Tamhane’s T2). Probability at 
p < 0.05 was considered statistically significant [14]. 
Sample size and statistical power analysis. The power 
analysis was performed in order to determine the sta-
tistical power (that is, the probability of obtaining a sta-
tistically significant effect, given that this effect exists 
in the population). The package GPower [15, 16] was 
used. Calculations were performed separately for the 
analysis of variance and the χ2 test. Cohen’s [17] cri-
teria for determining a small, medium and large effect 
size were used. The following results were obtained:
•	 for the ANOVA, the power to detect small (0.10), me-
dium (0.25), and large (0.40) effect sizes was 0.24, 
0.91, and 0.99, respectively;
•	 for the χ2, the power to detect small (0.10), medium 
(0.30), and large (0.50) effect sizes was 0.18, 0.96, 
and 0.99, respectively.
It must be borne in mind that in the above analy-
ses, the assumption of equal sample sizes was not met. 
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Therefore, the results should be treated with caution. 
Nevertheless, in general it follows that the power to de-
tect significant effects was satisfactory in the case of 
medium and large effects, and somewhat smaller in the 
case of small effect sizes.
The study gained the approval of the Bioethi-
cal Committee of the Jagiellonian University (No. 
KBET/242/B/2002). Participation in the study was vol-
untary, and participant anonymity was ensured.
Results
The average age of pre-menopausal women was 
42.8 ± 6.3 years, and of postmenopausal women – 55.4 
± 4.9 years: 55.7 ± 4.9 years in naturally and 53.9 ± 
4.7 years in surgically menopausal women. The highest 
share (44.7%) was women aged from 45 to 55, followed 
by the 56-65 and 36-44 year brackets (24.2% and 
24.2%, respectively). Women aged 30-35 accounted for 
only 6.8% of the total.
A statistically significant age difference (p < 0.001) 
was identified between groups K1 and K2a, and K1 
and K2b, while groups K2a and K2b did not differ sig-
nificantly (p = 0.391). Age differences are presented 
in Table I.
The proportion of women currently smoking was 
higher (22%) in the group of menstruating women (K1) 
than in the other two groups, K2a and K2b (15.9% and 
16.6%, respectively); however the differences between 
the groups were not statistically significant (Table I).
Increased systolic blood pressure (≥ 140 mmHg) was 
observed in 14.2% of women. Compared to pre-meno-
pausal women (K1), significantly higher systolic blood 
pressure levels were present both in naturally (K2a) and 
surgically (K2b) menopausal women, p < 0.001 (Table I).
Compared with K1 women, women in K2a and K2b 
groups had significantly higher average total cholester-
ol levels, p < 0.05 (Table I).
The absolute risk score, according to the SCORE in 
the groups of pre- and post-menopausal women groups 
showed significant risk level differences (p < 0.001). 
A high risk (≥ 5%) was found in 14.3% of women in K2 
as compared to 0.9% in K1 group. 
The average 10-year risk of a  fatal cardiovascular 
incident was significantly higher among K2a (2.61%) 
and K2b (2.32%) women as compared to the menstru-
ating women – K1 (0.38%). No difference was, however, 
discovered between the group of naturally (K2a) and 
surgically (K2b) menopausal women (Table I). 
Discussion
The present study uses the risk of death in the 
coming 10 years, as resulting from estimates based 
on SCORE studies, whose participants also included 
Poland, as a  point of reference [7]. Following the rec-
ommendations of the Polish Forum for Prevention of 
Cardiovascular Diseases (PFP) [18], our study used the 
SCORE risk assessment system for high CVD risk coun-
tries. It showed that the risk of CVD-related fatality in-
creases by the factor over fifteen between the groups 
of pre- and post-menopausal women. This statistically 
significant increase takes place in a period of 13 years, 
as the average age in the group of menstruating women 
Tab. I. Comparison of selected risk factor for cardiovascular disease and level of risk SCORE in three groups of women (K1, K2a, K2b)
Mean (X ± SD)
Risk factors K1 (n = 113) K2a (n = 88) K2b (n = 18) p F F REGW
Age (years) 42.81 ± 6.32 55.78 ± 4.97 53.94 ± 4.78 < 0.001 130.02 k1-k2a, k1-k2b
Systolic blood pressure 
(SBP) (mm Hg)
116.32 ± 13.30 129.55 ± 18.29 124.31 ± 3.47 < 0.001 18.12 k1-k2a, k1-k2b
Total cholesterol (Tch) 
(mmol/l)
4.98 ± 0.94 5.68 ± 1.03 5.58 ± 1.16 < 0.001 12.86 k1-k2a, k1-k2b
Smoking (declared) K1; n (%) K2a; n (%) K2b; n (%)
No, I’ve never smoked 57 (50.44) 55 (62.50) 9 (50.00)
Yes, I currently smoke 25 (22.12) 14 (15.91) 3 (16.67)
Yes, I used to smoke 31 (27.43) 19 (21.59) 6 (33.33)
Total 113; 100 88; 100 18; 100 0.465
Mean (X ± SD)
K1 (n = 113) K2a (n = 88) K2b (n = 18) p F F REGW
CVD risk 10 scores (%) 0.38 ± 0.80 2.61 ± 3.58 2.32 ± 3.38 < 0.001 20.40 k1-k2a, k1-k2b
K1 – menstruating women, K2a – naturally post-menopausal women, K2b – surgically post-menopausal women
*Difference between the three groups significant at 0.05
F REGW – test F Ryana-Einota-Gabriela-Welscha, CVD – cardiovascular disease
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was 42.8 ± 6.3 years, while among post-menopausal 
women it ranged from 55.4 ± 4.9 years (naturally meno-
pausal women) to 53.9 ± 4.7 years (surgically menopau-
sal women). It should be emphasised that the largest 
group among the patients comprised women aged from 
45 to 55 years (44.7%), i.e. the age when peri-meno-
pausal hormonal changes and menopause occur [19].
Unlike in our research, in a  study on 1168 people 
(including 765 women and 403 men) aged from 35 to 
55 covered by primary health care in the Łomża and 
Kolno districts, Pędziński et al. claimed that the risk was 
low < 5% in all women, yet no account for the meno-
pausal status of women in this study was done [20].
Our results are consistent with the recommenda-
tions published by the Polish Forum for Prevention con-
cerning prevention of CVD and revealing that major CVD 
risk factors (arterial hypertension, dyslipidaemia, smok-
ing, obesity, diabetes, low level of physical activities, and 
improper diet) are similar in women and men. However, 
the strength of correlation between individual factors 
and the CVD risk differs between two genders, e.g. di-
abetes more gravely increases the CVD risk in women 
than in men. The Polish Forum for Prevention indicated 
that recommendations for non-pharmacological and 
pharmacological prevention are also the same for men 
and women. The Forum emphasises that no hormone re-
placement therapy should be started and continued for 
the prevention of CVD in postmenopausal women [18].
SCORE-based interpretation of the cardiovascular 
risk in women requires attention paid to a number of 
significant elements. First, estimates of the value of an 
absolute CVD risk in peri-menopausal and early post-
menopausal women may be underestimated due to 
the age shift between women and men, in prevalence 
of cardiovascular events, especially leading to death. 
Secondly, the low absolute risk of fatal events in the 
following 10 years, observed in the peri-menopausal 
period, may obscure a significant increase in the rela-
tive risk. That is why the Polish Forum for Prevention 
and the ESC consequently recommend using panels 
designed for 60-year-olds for this group. To illustrate 
changes in the lifestyle that contribute to risk reduction 
and mitigation of its escalation, taking place with age 
to a young person, relative risk tables can be used [7, 
12, 13, 18]. In this case, the European guidelines (2012) 
suggest that also the calculation of the individual’s risk 
age can be beneficial. Additional factors that influence 
the cardiovascular risk (such as HDL cholesterol, glu-
cose concentration, and body mass) can be covered 
via the HeartScore electronic risk assessment system 
(www.heartscore.org) [13]. Although the evaluation we 
present refers to an age group that is coherent with the 
age of the respondents, we discovered a fifteen times 
higher risk of death in the group of postmenopausal 
women. Thirdly, SCORE underestimates the risk in peo-
ple with low HDL cholesterol levels, elevated triglycer-
ides, impaired glucose tolerance, and high activity of 
inflammatory markers. These features are important 
components of the metabolic syndrome, which a num-
ber of authors believe to be the basic factor in deter-
mining the CVD risk in post-menopausal women [12, 
21]. In our work we limited ourselves to present only 
the data covered by SCORE assessment.
The result of our study suggests that women in the 
peri-menopausal period, and especially after the meno-
pause, should have been SCORE-assessed for the risk 
of developing CVDs and ensuing complications. The es-
timated individual absolute risk SCORE value may be 
helpful in undertaking necessary evidence-based pre-
vention; as such risk is often underestimated in every-
day practice [21].
The weaknesses of our study is the limited size of 
the sample and lack of random participant selection. 
It is so as the study involved only women interested in 
their health state. 
We assume that the health situation among other 
women in the same age group, who were not interested 
in participation in this study, was not necessarily bet-
ter. Generally, persons who take active interest in their 
health, are expected to live a healthier lifestyle.
On the other hand, the fact that selection to both 
the groups of women (i.e. before and after menopause) 
followed the same principles supports the reliability of 
the results presented.
Due to the lack of randomization (which, for obvi-
ous reasons, was not possible), the results should be 
treated with some caution. The study could have suf-
fered from overrepresentation of patients after surgi-
cal menopause since such patients are more concerned 
about their health state than those menstruating or af-
ter natural menopause. 
Conclusions 
Presented results indicate that not only the inten-
sity of symptoms of the climacteric syndrome, but also 
the cardiovascular risk should be assessed in women at 
menopausal age.
According to SCORE, a  significantly higher risk of 
death resulting from cardiovascular incidents in the fol-
lowing 10 years is characteristic of women in the post-
menopausal period as compared with premenopausal 
women.
Research suggests the need to include pre- and 
post-menopausal women, even without symptomatic 
CVD, in preventative actions in order to adjust their life-
styles and risk factors to the principles of primary CVD 
prevention.
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